← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Luminary Therapeutics, Inc.
Minneapolis, MN
$3,357,355
Total funding
5
Grants
Funding over time
peak $1.5M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,357,355 · 5
By mechanism
R44$1,861,249 · 1
R43$1,496,106 · 4
Investigators at Luminary Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies$1,463,315
R44 · FY2025 · CA
Simultaneous Targeting of Tumor and Stroma Cells to Enhance Solid Tumor CAR-T Cell Therapy$399,658
R43 · FY2021 · CA
An allogeneic gamma/delta armored Dual-Targeting CAR with Split Costimulatory Domains to Target Epithelial Ovarian Carcinoma$399,256
R43 · FY2024 · CA
Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies$397,934
R44 · FY2023 · CA
MyD88 fusion protein with antigen specific T Cell therapy for enhanced response in solid tumors$397,422
R43 · FY2020 · CA
Allogeneic BAFF Ligand Based CAR T-Cells as a Novel Therapy for Systemic Lupus Erythematous$299,770
R43 · FY2023 · AI